RLS Global AB (publ)
RLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden.
RLS Global AB (publ) (RLS) - Total Assets
Latest total assets as of June 2023: Skr23.51 Million SEK
Based on the latest financial reports, RLS Global AB (publ) (RLS) holds total assets worth Skr23.51 Million SEK as of June 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
RLS Global AB (publ) - Total Assets Trend (2006–2022)
This chart illustrates how RLS Global AB (publ)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
RLS Global AB (publ) - Asset Composition Analysis
Current Asset Composition (December 2022)
RLS Global AB (publ)'s total assets of Skr23.51 Million consist of 62.4% current assets and 37.6% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 53.0% |
| Accounts Receivable | Skr404.00K | 1.0% |
| Inventory | Skr582.00K | 1.5% |
| Property, Plant & Equipment | Skr3.93 Million | 10.2% |
| Intangible Assets | Skr8.40 Million | 21.7% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2006–2022)
This chart illustrates how RLS Global AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: RLS Global AB (publ)'s current assets represent 62.4% of total assets in 2022, a decrease from 70.1% in 2006.
- Cash Position: Cash and equivalents constituted 53.0% of total assets in 2022, up from 0.0% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 21.0% of total assets, a decrease from 25.0% in 2006.
- Asset Diversification: The largest asset category is intangible assets at 21.7% of total assets.
RLS Global AB (publ) Competitors by Total Assets
Key competitors of RLS Global AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Biostar Pharmaceuticals Inc
PINK:BSPM
|
USA | $41.43 Million |
|
High Sierra Technologies Inc
PINK:HSTI
|
USA | $10.70K |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
RLS Global AB (publ) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - RLS Global AB (publ) generates 0.03x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - RLS Global AB (publ) is currently not profitable relative to its asset base.
RLS Global AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.13 | 0.78 | 5.62 |
| Quick Ratio | 1.06 | 0.64 | 5.49 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr929.00K | Skr -2.58 Million | Skr 25.61 Million |
RLS Global AB (publ) - Advanced Valuation Insights
This section examines the relationship between RLS Global AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.14 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | 45.5% |
| Total Assets | Skr38.71 Million |
| Market Capitalization | $2.87 Million USD |
Valuation Analysis
Below Book Valuation: The market values RLS Global AB (publ)'s assets below their book value (0.07 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: RLS Global AB (publ)'s assets grew by 45.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for RLS Global AB (publ) (2006–2022)
The table below shows the annual total assets of RLS Global AB (publ) from 2006 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | Skr38.71 Million | +45.54% |
| 2021-12-31 | Skr26.60 Million | -24.59% |
| 2020-12-31 | Skr35.27 Million | -39.95% |
| 2019-12-31 | Skr58.74 Million | +50.82% |
| 2018-12-31 | Skr38.94 Million | -34.23% |
| 2017-12-31 | Skr59.22 Million | +377.02% |
| 2016-12-31 | Skr12.41 Million | +31.50% |
| 2015-12-31 | Skr9.44 Million | +33.58% |
| 2014-12-31 | Skr7.07 Million | -4.51% |
| 2013-12-31 | Skr7.40 Million | -11.49% |
| 2012-12-31 | Skr8.36 Million | +8.58% |
| 2011-12-31 | Skr7.70 Million | +2.47% |
| 2010-12-31 | Skr7.52 Million | -97.00% |
| 2009-12-31 | Skr250.23 Million | +35.14% |
| 2008-12-31 | Skr185.16 Million | -4.35% |
| 2007-12-31 | Skr193.58 Million | +21.43% |
| 2006-12-31 | Skr159.41 Million | -- |